HighTower Advisors LLC lifted its stake in shares of Corcept Therapeutics Incorporated (NASDAQ:CORT – Free Report) by 30.7% ...
NEW YORK, NY / ACCESS Newswire / March 18, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Corcept ...
Hosted on MSN16d
Q4 Earnings Outperformers: Corcept (NASDAQ:CORT) And The Rest Of The Branded Pharmaceuticals StocksOn average, they are relatively unchanged since the latest earnings results. Founded in 1998, Corcept Therapeutics (NASDAQ:CORT) develops and commercializes medications for the treatment of severe ...
Corcept Therapeutics (CORT) announced the initiation of MOMENTUM, a clinical trial examining the prevalence of endogenous ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results